Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karoly Toth

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Viruses|June 14, 2017
HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster ModelKaroly Toth, Jacqueline F Spencer, Baoling Ying, et al.
International Reviews of Immunology|December 24, 2003
Functions and mechanisms of action of the adenovirus E3 proteinsDrew L Lichtenstein, Karoly Toth, Konstantin Doronin, et al.
FEMS Microbiology Reviews|March 28, 2019
Drug development against human adenoviruses and its advancement by Syrian hamster modelsWilliam S M Wold, Ann E Tollefson, Baoling Ying, et al.
Virology|February 8, 2003
Overexpression of the ADP (E3-11.6K) protein increases cell lysis and spread of adenovirusKonstantin Doronin, Karoly Toth, Mohan Kuppuswamy, et al.
Cancer Letters|August 30, 2011
Augmented therapeutic efficacy of irinotecan is associated with enhanced drug accumulationRami G Azrak, Shousong Cao, Farukh A Durrani, et al.
Virus Research|February 1, 2005
Adenovirus immunoregulatory E3 proteins prolong transplants of human cells in immunocompetent miceKaroly Toth, Konstantin Doronin, Mohan Kuppuswamy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 7, 2023
Targeting Lin28 axis enhances glypican-3-CAR T cell efficacy against hepatic tumor initiating cell populationTapas Patra, David M Cunningham, Keith Meyer, et al.
Journal of Virology|October 28, 2004
Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2Drew L Lichtenstein, Konstantin Doronin, Karoly Toth, et al.
BMC Cancer|July 19, 2012
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibitionSreenivasulu Chintala, Tanbir Najrana, Karoly Toth, et al.
Bioorganic & Medicinal Chemistry|November 16, 2023
Identification of Ebselen derivatives as novel SARS-CoV-2 main protease inhibitors: Design, synthesis, biological evaluation, and structure-activity relationships explorationHeng Zhang, Jing Li, Karoly Toth, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Viruses|June 14, 2017
HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster ModelKaroly Toth, Jacqueline F Spencer, Baoling Ying, et al.
International Reviews of Immunology|December 24, 2003
Functions and mechanisms of action of the adenovirus E3 proteinsDrew L Lichtenstein, Karoly Toth, Konstantin Doronin, et al.
FEMS Microbiology Reviews|March 28, 2019
Drug development against human adenoviruses and its advancement by Syrian hamster modelsWilliam S M Wold, Ann E Tollefson, Baoling Ying, et al.
Virology|February 8, 2003
Overexpression of the ADP (E3-11.6K) protein increases cell lysis and spread of adenovirusKonstantin Doronin, Karoly Toth, Mohan Kuppuswamy, et al.
Cancer Letters|August 30, 2011
Augmented therapeutic efficacy of irinotecan is associated with enhanced drug accumulationRami G Azrak, Shousong Cao, Farukh A Durrani, et al.
Virus Research|February 1, 2005
Adenovirus immunoregulatory E3 proteins prolong transplants of human cells in immunocompetent miceKaroly Toth, Konstantin Doronin, Mohan Kuppuswamy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 7, 2023
Targeting Lin28 axis enhances glypican-3-CAR T cell efficacy against hepatic tumor initiating cell populationTapas Patra, David M Cunningham, Keith Meyer, et al.
Journal of Virology|October 28, 2004
Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2Drew L Lichtenstein, Konstantin Doronin, Karoly Toth, et al.
BMC Cancer|July 19, 2012
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibitionSreenivasulu Chintala, Tanbir Najrana, Karoly Toth, et al.
Bioorganic & Medicinal Chemistry|November 16, 2023
Identification of Ebselen derivatives as novel SARS-CoV-2 main protease inhibitors: Design, synthesis, biological evaluation, and structure-activity relationships explorationHeng Zhang, Jing Li, Karoly Toth, et al.
Pageof 7